Follow
Yue-Xuan Li
Yue-Xuan Li
Scribe Therapeutics, Inc.
Verified email at umn.edu
Title
Cited by
Cited by
Year
SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy
Y You, WZ Li, S Zhang, B Hu, YX Li, HD Li, HH Tang, QW Li, YY Guan, ...
Journal of hepatology 69 (1), 129-141, 2018
592018
Macropinocytosis as a cell entry route for peptide-functionalized and bystander nanoparticles
YX Li, HB Pang
Journal of controlled release 329, 1222-1230, 2021
362021
Protective effects of a traditional Chinese herbal formula Jiang-Xian HuGan on concanavalin A-induced mouse hepatitis via NF-κB and Nrf2 signaling pathways
HH Tang, HL Li, YX Li, Y You, YY Guan, SL Zhang, LX Liu, WL Bao, ...
Journal of ethnopharmacology 217, 118-125, 2018
152018
Synergistic entry of individual nanoparticles into mammalian cells driven by free energy decline and regulated by their sizes
Y Wei, H Chen, YX Li, K He, K Yang, HB Pang
ACS nano 16 (4), 5885-5897, 2022
142022
Transportan peptide stimulates the nanomaterial internalization into mammalian cells in the bystander manner through macropinocytosis
YX Li, Y Wei, R Zhong, L Li, HB Pang
Pharmaceutics 13 (4), 552, 2021
142021
Co-Administration of transportan peptide enhances the cellular entry of liposomes in the bystander manner both in vitro and in vivo
YX Li, N Wang, MM Hasan, HB Pang
Molecular pharmaceutics 19 (11), 4123-4134, 2022
82022
Peptide targeting improves the delivery and therapeutic index of glucocorticoids to treat rheumatoid arthritis
X Wu, H Guo, H Gao, Y Li, X Hu, MA Kowalke, YX Li, Y Wei, J Zhao, ...
Journal of Controlled Release 368, 329-343, 2024
2024
Identification of an ALK‐2 Inhibitor as an Agonist for Intercellular Exchange and Tumor Delivery of Nanomaterial
X Wu, H Guo, J Zhao, Y Wei, YX Li, HB Pang
Advanced therapeutics 6 (2), 2200173, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–8